Trinity Biotech (TRIB) EBT Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -51.14% |
| Sep 30, 2024 | -31.10% |
| Jun 30, 2024 | -36.97% |
| Mar 31, 2024 | -26.72% |
| Dec 31, 2023 | -31.15% |
| Sep 30, 2023 | -37.02% |
| Jun 30, 2023 | -53.25% |
| Mar 31, 2023 | -32.80% |
| Dec 31, 2022 | -48.62% |
| Sep 30, 2022 | -41.66% |
| Jun 30, 2022 | -40.02% |
| Mar 31, 2022 | -48.96% |
| Dec 31, 2021 | 43.68% |
| Sep 30, 2021 | 44.68% |
| Jun 30, 2021 | -15.52% |
| Mar 31, 2021 | 41.54% |
| Dec 31, 2020 | 27.54% |
| Sep 30, 2020 | -3.95% |
| Jun 30, 2020 | -9.97% |
| Mar 31, 2020 | -7.47% |
| Dec 31, 2019 | -9.05% |
| Sep 30, 2019 | -11.21% |
| Jun 30, 2019 | -11.86% |
| Mar 31, 2019 | -10.75% |
| Dec 31, 2018 | -10.03% |
| Sep 30, 2018 | -14.38% |
| Jun 30, 2018 | -6.82% |
| Mar 31, 2018 | -7.35% |
| Dec 31, 2017 | -16.51% |
| Sep 30, 2017 | -11.34% |
| Jun 30, 2017 | -9.21% |
| Mar 31, 2017 | -11.93% |
| Dec 31, 2016 | -61.87% |
| Sep 30, 2016 | -15.77% |
| Jun 30, 2016 | -13.12% |
| Mar 31, 2016 | -17.80% |
| Dec 31, 2015 | -5.60% |
| Sep 30, 2015 | 32.17% |
| Jun 30, 2015 | -43.53% |
| Mar 31, 2015 | 4.59% |
| Dec 31, 2014 | 5.97% |
| Sep 30, 2014 | 6.14% |
| Jun 30, 2014 | 5.62% |
| Mar 31, 2014 | 10.45% |